Remedent Engages Liolios Group to Lead New Investor Relations Program
February 17 2009 - 7:30AM
Marketwired
Remedent, Inc. (OTCBB: REMI), an international company specializing
in the research, development, and manufacturing of oral care and
cosmetic dentistry products, has engaged Liolios Group, Inc. to
lead a new investor relations and financial communications program.
"Liolios Group brings a proven ability to generate results for
emerging growth companies looking to build quality, long-term
relationships with investors, analysts, money managers and
institutions," said Remedent CEO Guy De Vreese. "We have arrived at
a pivotal stage in our development that has made it important for a
team of experienced professionals like Liolios Group to deliver our
message more effectively to our shareholders and raise our profile
in the investment community."
Liolios Group will collaborate with Remedent's management to
redefine the company's message and outline a new communications
strategy, including identifying key performance metrics investors
should focus upon as they track the company's progress. Liolios
Group will also schedule a number of conference calls, road shows,
and financial conferences over the next several months, targeting
investors and key influencers such as analysts, fund managers,
investment advisors, and members of the financial press.
To receive a corporate profile on Remedent or schedule meetings
with company management, please contact Liolios Group at (949)
574-3860 or email info@liolios.com.
About Liolios Group
Liolios Group, Inc. is a highly selective and comprehensive
investor relations firm specializing in small and micro-cap
companies. The company aims to deliver superior performance in
corporate messaging and positioning, investor awareness, analyst
and financial press coverage, and capital attraction. Founded in
1996 in Newport Beach, California, Liolios Group partners all have
more than 15 years experience in finance and investments, and have
represented more than 100 companies in a wide range of industries.
For more information about Liolios Group, go to
www.liolios.com.
About Remedent
Remedent, Inc. specializes in the research, development,
manufacturing and marketing of oral care and cosmetic dentistry
products. The company serves the dental community with unique
veneer, teeth whitening and sensitivity products that are
recognized for their technological superiority and
ease-of-application. Headquartered in Belgium, and with offices in
California and Singapore, Remedent distributes its products to more
than 35 countries worldwide.
Company Contacts: Stephen Ross CFO Remedent, Inc. Tel
310-922-5685 Email Contact Investor Relations: Ron Both Managing
Director Liolios Group, Inc. Tel (949) 574-3860 Email Contact
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024